CA2398695A1 - Peptide apparente a la chondromoduline-i - Google Patents

Peptide apparente a la chondromoduline-i Download PDF

Info

Publication number
CA2398695A1
CA2398695A1 CA002398695A CA2398695A CA2398695A1 CA 2398695 A1 CA2398695 A1 CA 2398695A1 CA 002398695 A CA002398695 A CA 002398695A CA 2398695 A CA2398695 A CA 2398695A CA 2398695 A1 CA2398695 A1 CA 2398695A1
Authority
CA
Canada
Prior art keywords
polypeptide
chmirp
seq
amino acid
set forth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002398695A
Other languages
English (en)
Inventor
Hung Nguyen
Jeannie Jung
Kristie Clarkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2398695A1 publication Critical patent/CA2398695A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne un nouveau polynucléotide codant un polypeptide dont la structure est proche de celle de la chondromoduline-I, ainsi que la protéine purifiée elle-même. Cette invention concerne également des vecteurs, des cellules hôtes, des anticorps et des procédés de recombinaison qui permettent de produire les polypeptides, ainsi que des applications dans les domaines de la thérapie, du diagnostic et de la recherche pour ces produits et les produits apparentés.
CA002398695A 2000-01-19 2001-01-18 Peptide apparente a la chondromoduline-i Abandoned CA2398695A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17689800P 2000-01-19 2000-01-19
US60/176,898 2000-01-19
US72431000A 2000-11-28 2000-11-28
US09/724,310 2000-11-28
PCT/US2001/001700 WO2001053344A2 (fr) 2000-01-19 2001-01-18 Peptide apparente a la chondromoduline-i

Publications (1)

Publication Number Publication Date
CA2398695A1 true CA2398695A1 (fr) 2001-07-26

Family

ID=26872727

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002398695A Abandoned CA2398695A1 (fr) 2000-01-19 2001-01-18 Peptide apparente a la chondromoduline-i

Country Status (7)

Country Link
EP (1) EP1261639A2 (fr)
JP (1) JP2003520590A (fr)
AR (1) AR027238A1 (fr)
AU (1) AU3647701A (fr)
CA (1) CA2398695A1 (fr)
MX (1) MXPA02007119A (fr)
WO (1) WO2001053344A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60044138D1 (de) 1999-09-29 2010-05-20 Teijin Ltd POLYPEPTIDE UND FüR DIESE KODIERENDE GENE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3585180B2 (ja) * 1993-05-11 2004-11-04 三菱化学株式会社 新規なヒトタンパク質およびそれをコードする遺伝子
CA2319089A1 (fr) * 1998-04-09 1999-10-21 Genset S.A. Etiquettes de sequences exprimees (est) des 5' et proteines humaines codees
CA2339043A1 (fr) * 1998-09-01 2000-03-09 Genentech, Inc. Nouveaux pro-polypeptides et sequences correspondantes
AU1622200A (en) * 1998-11-13 2000-06-05 Zymogenetics Inc. Mammalian chondromodulin-like protein
EP1144614A4 (fr) * 1999-01-19 2003-08-06 Human Genome Sciences Inc Proteines humaines secretees (33)
AU2883700A (en) * 1999-06-23 2001-01-09 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU7573000A (en) * 1999-09-01 2001-03-26 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE60044138D1 (de) * 1999-09-29 2010-05-20 Teijin Ltd POLYPEPTIDE UND FüR DIESE KODIERENDE GENE
WO2001048203A1 (fr) * 1999-12-27 2001-07-05 Takeda Chemical Industries, Ltd. Nouvelle proteine et adn associe
JP2001299363A (ja) * 1999-12-27 2001-10-30 Takeda Chem Ind Ltd 新規タンパク質およびそのｄｎａ

Also Published As

Publication number Publication date
WO2001053344A2 (fr) 2001-07-26
AU3647701A (en) 2001-07-31
EP1261639A2 (fr) 2002-12-04
WO2001053344A3 (fr) 2002-01-03
AR027238A1 (es) 2003-03-19
MXPA02007119A (es) 2003-04-14
JP2003520590A (ja) 2003-07-08

Similar Documents

Publication Publication Date Title
US20060191027A1 (en) Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof
US6521422B1 (en) Fhm, a novel member of the TNF ligand supergene family
CA2403572A1 (fr) Molecules analogues au recepteur du facteur de croissance du fibroblaste, et leurs utilisations
US20050277151A1 (en) NTR3, a novel member of the TNF- receptor supergene family
US7041796B2 (en) C3b/C4b Complement Receptor-like molecules and uses thereof
AU2001251082B2 (en) CD20/IgE-receptor like molecules and uses thereof
AU2001251082A2 (en) CD20/IgE-receptor like molecules and uses thereof
AU2001251082A1 (en) CD20/IgE-receptor like molecules and uses thereof
US20040018544A1 (en) Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
CA2398695A1 (fr) Peptide apparente a la chondromoduline-i
AU2006200794A1 (en) Fhm, A novel member of the TNF ligand supergene family
AU2006202629A1 (en) Chondromodulin-I Related Peptide
JP2004500105A (ja) Ｔ細胞シグナル伝達のアポリポタンパク質−ａ−１調節
AU2007201047A1 (en) CD20/lgE-Receptor Like Molecules and Uses Thereof
AU2007200628A1 (en) Cystine-Knot Polypeptides: Cloaked-2 Molecules and Uses Thereof
AU2005209710A1 (en) Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof
EP1268782A2 (fr) Regulation apo-a-i de la signalisations des lymphocytes t

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead